Stock Events

Stock Events

Biolife Sciences 

$0.000100
1
+$0.00+0%Tuesday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
911
Avg. Volume
0
Mkt Cap
318,348.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Aug 31Expected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q4 2020
Q1 2021
Q2 2021
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0026

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-2.73MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap138.47B
Intuitive Surgical produces robotic surgical systems, competing in the medical device innovation space similar to Biolife Sciences.
Medtronic
MDT
Mkt Cap110.49B
Medtronic offers medical technologies, services, and solutions, directly competing with Biolife Sciences in the healthcare solutions market.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation specializes in medical technologies, including surgical equipment, which competes with Biolife's product offerings.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific Corporation develops medical devices that are used in various interventional medical specialties, competing with Biolife Sciences.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories operates in multiple segments including medical devices, directly competing with Biolife Sciences in developing advanced medical technologies.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings, Inc. manufactures medical devices in orthopedics, a sector where Biolife Sciences could potentially expand or compete.
Edwards Lifesciences
EW
Mkt Cap49.08B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the high-tech medical device market like Biolife Sciences.
Baxter International
BAX
Mkt Cap12.14B
Baxter International Inc. develops, manufactures, and markets products that save and sustain lives, similar to Biolife Sciences' mission in healthcare.

About

BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.
Show More
CEO
Justin De Four
Employees
3
Country
United States
ISIN
US09076L1035

Listings

OTC Link
US
BLFE

0 Comments

Share your thoughts

FAQs

What is Biolife Sciences stock price today?▼
The current price of BLFE is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Biolife Sciences stock price performance more closely on the chart.
What is Biolife Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Biolife Sciences stocks are traded under the ticker BLFE.
Is Biolife Sciences stock price growing?▼
BLFE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Biolife Sciences has showed a +0% increase.
What is Biolife Sciences market cap?▼
Today Biolife Sciences has the market capitalization of 318,348.6
What were Biolife Sciences earnings last quarter?▼
BLFE earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biolife Sciences revenue for the last year?▼
Biolife Sciences revenue for the last year amounts to 0 USD.
What is Biolife Sciences net income for the last year?▼
BLFE net income for the last year is -2.73M USD.
How many employees does Biolife Sciences have?▼
As of November 1, 2026, the company has 3 employees.
In which sector is Biolife Sciences located?▼
Biolife Sciences operates in the Health & Wellness sector.
When did Biolife Sciences complete a stock split?▼
The last stock split for Biolife Sciences was on July 23, 2018 with a ratio of 1:75.
Where is Biolife Sciences headquartered?▼
Biolife Sciences is headquartered in Henderson, United States.